Brevan Howard Capital Management LP Invitae Corp Transaction History

Brevan Howard Capital Management LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$14.7 - $28.67 $870,798 - $1.7 Million	-59,238 Closed	0 $0
Q3 2021 Nov 12, 2021	SELL	$24.31 - $33.6 $160,008 - $221,155	-6,582 Reduced 10.0%	59,238 $1.68 Million
Q1 2021 May 14, 2021	SELL	$33.06 - $56.93 $890,305 - $1.53 Million	-26,930 Reduced 29.04%	65,820 $2.52 Million
Q4 2020 Feb 12, 2021	BUY	$39.09 - $57.4 $3.63 Million - $5.32 Million	92,750 New	92,750 $3.88 Million

2.12M

Ticker NVTA
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 235,266,000
Description
Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...

Get notified when there are updates to the investment portfolio of Brevan Howard Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Brevan Howard Capital Management LP with notifications on news.